Prix FOB
Obtenir le dernier prix|
- Minimum Order
Pays:
China
N ° de modèle:
68497-62-1
Prix FOB:
Localité:
-
Prix de commande minimale:
-
Commande minimale:
-
Packaging Detail:
-
Heure de livraison:
-
Capacité de Fournir:
-
Payment Type:
-
Groupe de produits :
-
China
Personne àcontacter lansky
nanhu road, Wuhan, Hubei
Coluracetam (BCI***0) is a nootropic drug of the racetam family.[2]
Coluracetam (formerly known as MKC***1) was initially developed and
tested by the Tanabe Pharma Corporation for Alzheimer's disease.
After the drug failed to reach endpoints in its clinical trials it
was in-licensed by BrainCells Inc for investigations into major
depression disorder (MDD), after being awarded a "Qualifying
Therapeutic Discovery Program Grant" by the state of California.[3]
Findings from its Phase 2a clinical trials have suggested that it
would be an ideal medication for co-morbid MDD with generalized
anxiety disorder (GAD).[4] BrainCells Inc is currently
out-licensing the drug for this purpose.[5] It may also have
potential use in prevention and treatment of ischemic retinopathy
and retinal and optic nerve injury.
Coluracetam has been shown to reverse the loss of choline
acetyltransferase production in the medial septal nucleus of rats
exposed to PCP, and is considered a potential therapeutic drug for
schizophrenia.
| Pays: | China |
| N ° de modèle: | 68497-62-1 |
| Prix FOB: | Obtenir le dernier prix |
| Localité: | - |
| Prix de commande minimale: | - |
| Commande minimale: | - |
| Packaging Detail: | - |
| Heure de livraison: | - |
| Capacité de Fournir: | - |
| Payment Type: | - |
| Groupe de produits : | - |
